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Abstract 
Background: This work aimed to provide useful information on the incidence of the choice of formulation in semi-
solid preparations of iron-oxide nanoparticles (IONs). The appropriate analytical methods to assess the IONs physical 
stability and the effect of the semi-solid preparations on IONs human skin penetration were discussed. The physi-
cal stability of IONs (Dh = 31 ± 4 nm; ζ = −65 ± 5 mV) loaded in five semi-solid preparations (0.3% w/v), namely 
Carbopol gel (CP), hydroxyethyl cellulose gel (HEC), carboxymethylcellulose gel (CMC), cetomacrogol cream (Cet) 
and cold cream was assessed by combining DLS and low-field pulsed NMR data. The in vitro penetration of IONs was 
studied using human epidermis or isolated stratum corneum (SC).
Results: Reversible and irreversible IONs aggregates were evidenced only in HEC and CMC, respectively. IONs dif-
fused massively through SC preferentially by an intercellular pathway, as assessed by transmission electron micros-
copy. The semi-solid preparations differently influenced the IONs penetration as compared to the aqueous suspen-
sion. Cet cream allowed the highest permeation and the lowest retained amount, while cold cream and CP favored 
the accumulation into the skin membrane.
Conclusion: Basic cutaneous semi-solid preparations could be used to administer IONs without affecting their per-
meation profile if they maintained their physical stability over time. This property is better discriminated by low-field 
pulsed NMR measurements than the commonly used DLS measurements.
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Background
Skin is one of the focuses for research in drug delivery 
with many drugs being evaluated for transdermal or der-
mal administration. However, penetration and retention 
of drugs into the epidermis is not a simple task. Indeed, 
the outermost layer of the skin, the stratum corneum 
(SC), is a barrier both to water transport out of the body 
and to inward chemical permeation. In addition to the 
physical barriers, the clearance of capillaries in the der-
mis and the cutaneous metabolism via local phase I and 
phase II metabolic enzymes can also reduce the local bio-
availability of drugs [1]. Among the possible approaches 
to overcome these issues, nanocarriers represent a new 
opportunity to improve the treatment of loco-regional 
diseases. For instance, nanoparticle dispersions (e.g., 
vesicles) have been applied to transcutaneous delivery of 
drugs, with some of them being commercialized and 
many more under clinical assessment [2].
Metal-based nanoparticles provide new perspec-
tives on particle absorption into/through the skin, since 
their particle size and shape could be tailored to favor 
the penetration of SC via the intercellular route [3–5]. 
Nevertheless, most of the studies hinge on the potential 
toxicity effect of the nanoparticles through the skin and 
the mechanism related to the interaction between nano-
particles and skin layers [6, 7]. Multifunctional colloidal 
nanoparticles have been designed to improve the delivery 
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of conventional drugs, peptides, vaccines or genes across 
biological barriers, including blood brain barrier, der-
mal, transdermal and intraocular delivery [8]. Among the 
plethora of metal-based colloidal nanoparticles, the use 
of iron oxide nanoparticles (IONs) appears of particu-
lar interest since they have been already used in several 
medical areas, including therapeutics and diagnostics, 
and, therefore, their safety profiles are already known [9, 
10]. In  vitro transdermal studies demonstrated that the 
IONs bearing antitumor drugs were able to penetrate the 
skin assisted by an applied magnetic field, suggesting a 
potential of IONs as drug delivery system for transdermal 
therapy of skin cancer [11].
However, the actual broad applicability of IONs in the 
clinical practice remains controversial due to contradic-
tory evidence on potential toxicity of colloidal nanopar-
ticles. Recent studies suggested that appropriate surface 
coating with “bio-friendly” materials might improve the 
nanoparticle stability in biological environment, reducing 
the oxidative stress mediated toxicological effects as well 
as immune and carcinogenic effects and preserving the 
physiological processes [12, 13].
Intravenous administration of colloidal nanoparticles 
is still matter of debate. Intravenous and oral administra-
tions of IONs formulations have been approved for clini-
cal use by the Food and Drug Administration (FDA) [14]. 
However, most intravenously administered compounds 
approved by FDA have been withdrawn from the mar-
ketplace [15], with the exception of some therapeutics 
indicated for the treatment of iron deficiency anemia in 
adults [16]. IONs for oral administration remain on the 
market for use as an oral gastrointestinal contrast agent 
in MR imaging (i.e., Gastromark® and Ferumoxsil-con-
taining products) [17]. For these reasons, the skin pen-
etration of IONs has been gaining increasing interest 
in nanomedicine [9, 18, 19]. It has been suggested that 
IONs with a diameter smaller than 40  nm were able to 
penetrate the intercellular space among keratinocytes 
of the SC [18] and 10  nm-IONs were able to penetrate 
the human epidermis (HE), without reaching the der-
mal layer [20]. In addition, the IONs polymeric coating, 
which is required to obtain a colloidal solution stable 
both in water and in physiologic media, should be care-
fully selected since an isoelectric point similar to that of 
human skin would favor the formation of IONs clusters 
at the skin interface, preventing their permeation [20].
In a preliminary study, IONs coated by a poly-
(isobutylene-alt-maleic anhydride) (PMA-IONs) were 
demonstrated to accumulate in ex  vivo full-thickness 
human skin and in mice skin after topical application 
in  vivo [21]. However, physicochemical attributes, such 
as size, surface charge, surface chemistry, and physi-
cal state of the nanoparticles are not the only critical 
determinants for their skin permeation. Indeed, the dif-
fusion performance relies also on the physicochemical 
properties and composition of the semi-solid formulation 
required to obtain a suitable cutaneous product. Such a 
vehicle includes other excipients to afford the lubricity 
and spreading properties, the desired residence time on 
skin and the patient compliance. Although the stability of 
IONs, or more in general of nanoparticles, in the vehicle 
has been one of the major critical factors that could affect 
the effectiveness of their topical administration, very few 
data were reported in literature. In particular, no system-
atic studies have been carried out to investigate the influ-
ence of semi-solid formulations on the physicochemical 
features of IONs and on their permeability across the 
human skin. Therefore, to rationalize the selection of a 
suitable vehicle for PMA-IONs administration, this work 
aimed to investigate the impact of semi-solid formula-
tions (i.e., hydrogels and o/w creams) on the physical 
stability of nanoparticles and on the in vitro penetration 
through HE.
Results
Formulation study of PMA‑IONs semi‑solid preparations
The protocol adopted for the production of PMA-IONs 
allowed to obtain monodisperse nanoparticles with a 
strongly negative surface charge (Fig. 1; Table 1). PMA-
IONs were loaded in three hydrogels, made of hydroxy-
ethyl cellulose (HEC), sodium carboxymethyl cellulose 
(CMC) and carbomer 974P (CP), and two hydrophilic 
creams, namely a cetomacrogol (Cet) cream and a cold 
cream. 
The physical stability of PMA-IONs loaded into the 
semi-solid formulations was determined according to 
two different methods, namely low-field pulsed NMR and 
dynamic light scattering (DLS), using the physicochemi-
cal features of the aqueous suspension as reference. The 
former technique was selected because it could provide 
direct characterization of the semi-solid preparation, 
while the latter allowed to assess the possible formation 
of nanoparticle aggregates or change in size.
Low-field pulsed NMR analysis provided information 
on the magnetic properties of nanoparticles, which are 
influenced by deviation in structure, surface composition, 
concentration and mobility. Hence, the measurement of 
the r2 value of PMA-IONs was a sensitive parameter to 
characterize changes in the nanoparticles mobility in dif-
ferent media because its variation suggested the forma-
tion of interactions among the formulation components. 
As expected, the r2 value of the nanoparticles suspension 
in aqueous solution did not significantly change within 
50  days of storage at 25  ±  2  °C, confirming the stabil-
ity of PMA-IONs in water. A similar trend was evident 
analyzing nanoparticles dispersed in both o/w cream 
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compositions (Additional file  1). Consequently, it might 
be assumed that neither aggregation nor alteration in 
size of iron oxide core occurred within this time win-
dow, as well as no modification of surface coating was 
detected over the time. The same trend was measured in 
the CP hydrogel. Conversely, in the case of HEC or CMC 
hydrogels, a sharp decrease of r2 values was noticed after 
one day of storage (Fig. 2a; Additional file 1). In particu-
lar, r2 value of CMC decreased due to PMA-IONs aggre-
gation followed by a precipitation that became visually 
noticeable after 30 days.
Unlike low-field pulsed NMR technique, DLS measure-
ments could not be performed directly on the semi-solid 
vehicles, but a prior sample dilution was required. Pre-
liminarily, placebo hydrogels and o/w creams were ana-
lyzed by DLS to evaluate possible interferences. Adapting 
the protocol of sample preparation, DLS technique could 
be used only for analyzing hydrogels. On the contrary, 
it could not be exploited to verify the physical state of 
PMA-IONs incorporated into o/w creams because the 
dispersed oily phase and the formulation viscosity did not 
allow to obtain reproducible results, despite the dilution. 
As depicted in Fig.  2b, the DLS trends found for CMC 
and CP were almost superimposable during storage at 
25  °C: PMA-IONs loaded in CMC hydrogel confirmed 
to be unstable, whereas the CP hydrogel appeared physi-
cally stable using both techniques. Contradictory results 
were found in the case HEC. Even if the low-field pulsed 
NMR evidenced instability of PMA-IONs in HEC hydro-
gel, no aggregates were noticed by DLS technique. These 
different patterns might be explained considering that 
the cellulose chains were able to promote the formation 
of reversible aggregates of PMA-IONs, which were not 
detectable by DLS due to the sample dilution. The forma-
tion of such reversible aggregates might be also in agree-
ment with the very significant reduction of the absolute 
ξ values (Table  1), which did not undergo to significant 
Fig. 1 TEM images and dynamic light scattering (DLS) of iron oxide NPs (IONs) in organic solvent and water phase transfer using PMA amphiphilic 
polymer (PMA-IONs). Scale bars 10 nm
Table 1 Physical characterisation of  PMA-IONs and  PMA-
IONs-loaded hydrogels (mean ± SD, n = 3)
HEC hydroxyethyl cellulose, CMC sodium carboxymethyl cellulose, CP carbomer 
974P
Formulation Dh (nm) PDI ξ (mV) pH
PMA-IONs 31 ± 4 0.15 ± 0.04 −64.80 ± 4.91 7.0
HEC 29 ± 15 0.44 ± 0.05 −42.17 ± 1.68 5.0
CMC 47 ± 7 0.54 ± 0.03 −79.77 ± 2.00 6.5
CP 52 ± 4 0.29 ± 0.04 −72.83 ± 5.25 6.0
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variations over the considered time period (Additional 
file 1).
Increasing the storage temperature at 40  °C, the 
trends in DLS data were confirmed, although in case of 
IONs loaded in CMC hydrogel physical instability was 
observed after 4 days of storage (Additional file 1).
Due to the physical instability of PMA-IONs loaded in 
the CMC hydrogel, such vehicle was not considered wor-
thy for further investigations.
In vitro permeation studies
Transmission electron microscope (TEM) images 
showed the presence of nanoparticles both into the upper 
HE layers and near to the basal membrane of epidermis 
(Fig. 3). Indeed, after 24 h, PMA-IONs were found on the 
surface and close to the corneocytes, into the epidermis 
and near the basal membrane (Fig. 3). Figure 3F showed 
nanoparticles into a cell of the stratum lucidum inside the 
cytoplasm, while Fig.  3C showed nanoparticles close to 
desmosomes. Thus, even though PMA-IONs were pre-
sent in the extracellular matrix, they showed also affinity 
for the proteins of the intercellular junctions.
In order to identify correctly the nature of that nano-
particles revealed by the conventional TEM in the HE 
sample, the STEM/EDX analysis was also carried out 
[22]. The STEM images were collected in different sec-
tions of the same sample previously analyzed by con-
ventional TEM. Also STEM showed images with high 
degree of details. In particular, STEM micrographs 
show nanostructures close to the stratum corneum 
brighter than the other elements. These white regu-
lar spots are indicated by the white squares 1 and 2 
in Fig. 4 and another brighter area (Additional file 1). 
The higher brilliance of these elements suggests that 
they are more electron dense and heavy than the other 
parts of the sample, without providing information on 
their chemical composition. So, the EDX analysis was 
performed on these white spots pointing the electron 
beam directly on them to determine their elemental 
composition. The spectra reported on the right side 
of STEM micrographs evidenced the presence of the 
iron signals only in squares 1 and 2 of Fig. 4, confirm-
ing that the nanoparticles are IONs. The EDX spectra 
revealed also the presence of a weak C-signal and a 
strong Cu-signal, which was attributed to the epider-
mis and TEM grid used to support the analyzed sec-
tion, respectively.
This result was in agreement with the in vitro permea-
tion study. Indeed, after 24  h, the retained amounts of 
PMA-IONs in SC and VE, normalized by the weight of 
the epidermal layers, were 234 ± 101 and 308 ± 101 ng/
mg, respectively (Table 2).
In addition, the iron amount permeated through HE 
after exposure to PMA-IONs for 24 h (p < 0.01) was dou-
bled with respect to the pre-exposure HE, which was 
reported to contain traces of iron (Table 2) related to the 
intense mitotic activity of VE [23]. This finding suggested 
that PMA-IONs were able to permeate the SC barrier 
and to concentrate into the VE.
Membranes based on regenerated keratins (RKM) [24] 
were used to model the tendency of nanoparticles to dif-
fuse through intracellular pathway of SC, because the 
lower the permeation through RKM, the higher the affin-
ity of nanoparticles for the intracellular compartment of 
SC. The results showed that Q24,RKM (6.4 ± 0.1 μg/cm2) 
was in accordance with the Q24,HE values (Table 2).
On the other side, the Qret,RKM (28 ± 5 ng/mg) was sig-
nificantly lower than the value obtained through SC (p 
value: 0.024). Hence, it may be assumed that weak inter-
actions occurred between PMA-IONs and keratins and 
that PMA-IONs diffused preferentially through an inter-
cellular pathway [25]. This hypothesis was also in agree-
ment with the TEM microphotographs evidencing the 
presence of nanoparticles only in the interstitial spaces 
among keratinocytes (Fig. 3).
Fig. 2 Variation of the r2 (a) and Dh values (b) of PMA-IONs loaded in 
hydrogels made of HEC (grey, solid line), CMC (grey, dash line) and CP 
(black, solid line) over time. The water suspension of PMA-IONs (black, 
dash line) was used as control
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The components of the four semi-solid vehicles dif-
ferently influenced the skin penetration of PMA-IONs. 
With the exception of the HEC hydrogel, all formula-
tions significantly increased the permeated amount after 
24  h, while only CP hydrogel and cold cream were able 
to increase also the amount of PMA-IONs retained into 
the HE (Table  2). Although the Qret/Q24,HE ratio of all 
the tested semi-solid formulations were similar to that of 
aqueous suspension (i.e., about 0.67), the permeated iron 
amount from the Cet cream was one order of magnitude 
higher than the relative retention data (Qret/Q24,HE: 0.19), 
suggesting a higher tendency of PMA-IONs to permeate 
than to be retained into the HE when they were loaded in 
the Cet cream.
Discussion
The permeation of nanoparticles through human skin 
is still matter of debate. Indeed, scientific evidence sug-
gested that only those nanoparticles with size below the 
6–7  nm limit were able to permeate the healthy skin 
through the lipidic trans-epidermal, whereas nanomate-
rials larger than 36 nm could be preferentially absorbed 
by the aqueous pores or trans-follicular routes [18].
PMA-IONs proposed in the current work exhibited a 
significant penetration through the human epidermis. 
Indeed, both TEM microscopy and permeation stud-
ies supported the evidence that PMA-IONs permeate 
significantly through the SC and accumulated into the 
VE. This behavior resulted dissimilar from that described 
for two types of 10  nm-IONs stabilized with a different 
coating [20]. In both cases, the nanosystems permeated 
the SC without reaching the VE in a massive amount. 
Hypothesizing that PMA-IONs permeate human skin 
following the same concentration-gradient mechanism 
of smaller chemical molecules, such incongruities may 
be explained on the basis of the differences in the experi-
mental protocols, e.g. the type of membrane model. The 
experimental results of PMA-IONs were performed 
using HE, whereas full-thickness human skin has been 
used as membrane model by Baroli and co-authors. As 
discussed by Cross and Roberts, HE can model an in vivo 
“infinite dermal perfusion”, where the penetrated solute is 
fully removed from below the epidermal-dermal junction 
[26]. On the contrary, no clearance of solute from the 
dermis is expected using full thickness skin, suggesting 
that such membrane can be a model of in vivo “infinite 
dermal vasoconstriction”. In this context, the permeation 
profile of PMA-IONs may be increased by using an “infi-
nite dermal perfusion” model with respect to other mod-
els of cutaneous barrier.
Besides such differences in the experimental protocols, 
the incongruities between experimental and published 
results may be also explained by a different tendency to 
distribute and diffuse through  SC due to the different 
Fig. 3 Transmission electron microscopy (TEM) images of skin samples treated with semisolid-formulations loaded by PMA-IONs. Nanoparticles 
(arrows) singularly or in cluster were found in stratum corneum (A), in stratum lucidum (B), in stratum granulosum (C), in stratum spinosum close to 
desmosomes (D), in stratum basale (E) and in proximity of desmosomes (F). d desmosomes, h hemidesmosomes
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coating of IONs. The coated-IONs investigated by Baroli 
and co-authors were only stabilized in water by electro-
static interactions with sodium bis-(2-ethylhexyl) sulfo-
succinate or tetramethylammonium hydroxide, whereas 
the use of PMA provided several advantages. Indeed, the 
amphiphilic property of PMA allowed to improve the 
colloidal stability of nanoparticles at physiological pH 
and their surface functionalization taking advantage of 
the presence of activated carboxylic groups on the sur-
face. Another important advantage of the amphiphilic 
coating was that it could improve the IONs incorporation 
into a semi-solid formulation, their permeation through 
Fig. 4 On the left a STEM image of HE tissue with some IONs; b  enlargement of image a: the white squares highlight the areas of the EDX spectra. 
On the right the EDX spectra taken from the nanoparticles highlighted in b. The copper signals come from the TEM grid
Table 2 Results of permeation (Q24) and retention (Qret) studies of aqueous suspensions and semisolid preparations con-
taining 3 mg/mL of PMA-IONs
The data were reported as absolute values (A) or as normalize values with respect to blank (N) (mean ± SD; n = 3)
HEC hydroxyethyl cellulose, CMC sodium carboxymethyl cellulose, CP carbomer 974P, Cet cetomacrogol
Formulation Qret Q24 Qret/
Q24,HE
A (μg/cm2) N A (μg/cm2) N
Water suspension 2.91 ± 1.04 1.98 ± 0.70 4.35 ± 0.74 2.30 ± 0.14 0.67
HEC hydrogel 1.73 ± 0.34 1.18 ± 0.23 3.48 ± 0.30 1.84 ± 0.16 0.50
CP hydrogel 4.70 ± 0.25 3.19 ± 0.17 7.22 ± 2.40 3.83 ± 1.27 0.65
Cet cream 1.98 ± 0.57 1.34 ± 0.39 10.51 ± 2.46 5.57 ± 1.30 0.19
Cold cream 5.30 ± 0.74 3.60 ± 0.50 8.05 ± 4.50 4.26 ± 2.39 0.66
Blank 1.47 ± 0.08 1.00 ± 0.05 1.89 ± 0.26 1.00 ± 0.14 –
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hydrophobic/hydrophilic biological environment and 
their penetration of SC by increasing their affinity for 
keratin or lipids present in the SC.
To make the topical administration of nanosystems 
clinically acceptable, they should be incorporated in 
semi-solid preparations, namely complex vehicles that 
potentially could affect their permeation performances. 
Exception made for HEC, the results demonstrated that 
all the tested semi-solid vehicles improved PMA-IONs 
penetration through HE (Table  2). It is worth mention-
ing the behavior of the Cet cream, which determined the 
highest permeation of PMA-IONs through HE and, at 
the same time, the lowest retained amount. These find-
ings might suggest that the larger amount of surfactants 
used in its preparation, with respect to other tested for-
mulations, influenced the affinity of PMA-IONs for HE, 
enhancing their permeation. Such evidence was also in 
agreement with previous published data obtained in vivo 
using a semi-solid base with a very similar composi-
tion [21]. Furthermore, the in  vitro penetration results 
stressed how critical was the physical stability of nano-
particles in the semi-solid matrix for permeating through 
the skin. Indeed, the permeation of PMA-IONs loaded 
in HEC was significantly reduced in comparison to other 
formulations (Table 2). According to the r2 values, PMA-
IONs loaded in both HEC and CMC hydrogel changed 
their physical state within one week after preparation. 
Although such changes of their superficial properties 
were reversible (i.e., adsorption or weak interactions), 
both polymers caused a reduction of PMA-IONs pen-
etration through human epidermis. Therefore, the selec-
tion of a suitable semi-solid vehicle for the nanosystems 
should be rationalized on the basis of their physical sta-
bility at short and long term. The modifications of the 
physical properties of PMA-IONs loaded in hydrogels 
and o/w creams were dependent on the formulation fea-
tures. Thus, the application of a universal methodology to 
assess the physical stability of these systems could not be 
considered.
Our results demonstrated that DLS, which is routinely 
used for the characterization of liquid suspensions, was 
not the technique of election for semi-solid formula-
tions since the physical status of nanoparticles could be 
affected by the necessary dilution of the sample. More-
over, DLS was not able to discriminate among particles 
deriving from the excipients used for the formulation and 
to be applied to opaque products such as creams due to 
the signal interferences of the large droplets of the dis-
persed phase, even if it was used in backscattering mode. 
To overcome this issue, low-field pulsed NMR, which 
exploits the magnetic properties of the superparamag-
netic core of PMA-IONs, was conveniently proposed as 
an alternative to directly evidence changes of PMA-IONs 
dispersed in semi-solid matrices. By the comparison of 
the two analytical techniques, a wider versatility of low-
field pulsed NMR was clearly evidenced since it allowed 
the direct determination of the physical stability of para-
magnetic nanoparticles in opaque vehicles and it did not 
require any sample dilution. Furthermore, the former 
technique was more sensitive since it was able to high-
light also changes of PMA-IONs physical state that could 
affect their inability to penetrate the skin (e.g., HEC). As 
a matter of fact, the reduction of r2 values in the HEC 
hydrogel provided a fast evidence of the instability of 
PMA-IONs, which was in agreement with the permea-
tion data profile.
Conclusions
The current results support the use of superparamagnetic 
nanoparticles coated with PMA as a technological plat-
form for drug delivery to human epidermis after topical 
administration. The loading of PMA-IONs in semi-solid 
vehicles did not affect their permeation profile only if 
they maintained their stability over time.
Considering that the physical state of PMA-IONs in 
semi-solid preparations was the most critical attribute for 
in vitro permeation performances, the selection of appro-
priate analytical methods was underlined. In particular, 
the overall results demonstrated that low-field pulsed 
NMR allowed to better discriminate the physical stabil-
ity of superparamagnetic nanosystems in comparison to 
the conventionally utilized DLS measurements, due to 
the higher versatility and sensitivity. However, only these 
techniques provided a deeper insight into a very complex 
system, allowing to discriminate between irreversible 
and reversible changes in the physical states of paramag-
netic nanosystems. All the tested semi-solid formulations 
influenced the PMA-IONs penetration through HE; the 
Cet cream allowed the highest permeation and the low-
est retained amount while cold creams and CP hydro-
gels favored the nanoparticle accumulation into the skin 
membrane. These results suggest that these two very 
basic formulations are suitable to be conveniently used 
to administer PMA-IONs topically in order to improve 
the efficiency of colloidal nanoparticles in penetrating the 
skin layers.
Methods
Preparation of polymer coated superparamagnetic 
iron‑oxide nanoparticles
PMA-IONs were prepared following previously reported 
procedures [27–29]. Briefly, iron oxide nanoparticles 
were synthesized by solvothermal decomposition at 
high temperature in octadecene from iron oleate precur-
sor resulting in iron oxide core dispersed in chloroform 
with an average diameter of 12.21 ± 0.8 nm (i.e., IONs). 
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Afterward, 4 mg (0.43 nmols, determined by ICP meas-
urements) of IONs were transferred to water phase by 
mixing with 136  μL of 0.5  M solution of an amphiphi-
lic polymer [poly-(isobutylene-alt-1-tetradecenemaleic 
anhydride)], corresponding to 100 monomers. After 
evaporation under vacuum, 5 mL of pH 12 sodium borate 
buffer were added to the dried mixture to suspend the 
nanoparticles (i.e., PMA-IONs). PMA-IONs were twice 
washed in water. PMA-IONs were purified by electro-
phoresis gels as described elsewhere [30] and re-sus-
pended in water at a final concentration of 3 mg/mL.
Preparation of topical semi‑solid dosage forms containing 
PMA‑IONs
All the semi-solid formulations were prepared with 
decreased water content, which was subsequently 
replaced by the aqueous nanoparticles dispersion at the 
PMA-IONs at 0.6% w/v concentration after the produc-
tion. The final loading was fixed at 0.3% w/v. Briefly:
  • Hydroxyethyl cellulose (HEC) hydrogel: 2.5% w/w 
HEC previously wet by 10% w/w glycerol was dis-
persed in distilled water heated at about 40 °C under 
magnetic stirring.
  • Sodium carboxymethyl cellulose (CMC) hydrogel: 
5% w/w CMC previously wet by 10% w/w glycerol 
was dispersed in distilled water heated at about 60 °C 
under magnetic stirring.
  • Carboxypolymethylene (Carbomer 974P, CP) hydro-
gel: 0.8% w/w was dispersed in distilled water by a 
magnetic bar. Then, sodium EDTA and propylene 
glycol was added. Then, the mixture was neutralized 
by drop wise addition of a 10% w/v sodium hydroxide 
solution until the gel formation occurred. Amount of 
sodium hydroxide was adjusted to pH 7.
  • Cetomacrogol (Cet) cream was prepared by heat-
ing both the oily (i.e., cetomacrogol 1000, cetostearyl 
alcohol, liquid paraffin and petrolatum) and aqueous 
phase at the temperature of about 60 °C. Afterwards, 
the aqueous phase was added to the oily phase under 
constant stirring.
  • Cold cream was prepared by mixing 4% w/w Sepineo 
P600, 10% w/w almond oil and water.
In all cases, 0.025% w/v methyl-paraben and 0.075% 
w/v propyl-paraben were added to water in order to pre-
serve form bacteria and mold contamination.
Storage stability of PMA‑IONs loaded hydrogels 
and creams
PMA-IONs loaded hydrogels and creams were stored 
at 25 ± 3 and 40 ± 2 °C over a 2-month period. At pre-
determined data points, the formulations were visually 
inspected to evidence aggregate formations. The hydro-
dynamic diameter, zeta-potential and MRI relaxivity 
were also measured by DLS.
Morphology of IONs
The morphology of IONs was detected by TEM analysis, 
50 μg/mL of IONs were dispersed in hexane and 50 μg/
mL PMA-IONs were dispersed in water. A drop of the 
resulting solution was placed on a Formvar/carbon-
coated copper grid and air-dried. TEM images were 
obtained by a Tecnai G2 Spirit microscope (Oregon, 
USA) operating at 120 kV.
Dynamic light scattering (DLS) and zeta‑potential 
measurements
The mean hydrodynamic diameter of nanoparticle (Dh), 
PDI, and zeta-potential (ξ) were measured at 25  °C 
by DLS method. Aliquots of PMA-IONs suspensions 
and PMA-IONs-loaded semi-solid formulations were 
diluted 1:20 in HPLC-grade water, filtered with 0.22 μm 
nylon filter (VWR, USA) and analyzed by Zetasizer 
Nano ZS (Malvern Instruments Ltd, UK). According to 
the National Institute of Standards and Technology, a 
sample with a PDI  <  0.05 is considered monodisperse 
[31].
Evaluation of PMA‑IONs stability in the semi‑solid dosage 
forms by MRI relaxivity measurement
The study of the variation of the PMA-IONs relaxation 
time in the semi-solid formulations was made by low-
field pulsed NMR Spectrometer mq20 (Bruker The Min-
ispec, Italy). Aliquots 1  mL of were analyzed in a glass 
vial at 40 °C; a magnetic field was applied and, once the 
stimulus was interrupted, T2 relaxation time was meas-
ured. The relaxivity (r2) of PMA-IONs was calculated 
according the following equation (Eq. 1):
where (1/T2)sample was the inverse of relaxation time of 
the semisolid matrix containing PMA-IONs, (1/T2)control 
the inverse of relaxation time of the placebo semisolid 
matrix and the [PMA-IONs] was the concentration of 
nanoparticles in the semisolid matrix.
All the formulations were analyzed at the nanoparticles 
concentration of 0.15% w/v. Each analysis was conducted 
after 0, 2, 20, 32, 41 and 48 days from preparation (n = 3).
In vitro penetration studies
In vitro permeation and retention studies were per-
formed with the Franz diffusion cells using HE or SC, or a 
membrane based on regenerated keratin (RKM; 24).
(1)r2 =
(
1
T2
)
sample
−
(
1
T2
)
control
[PMA− IONs]
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HE was prepared from full-thickness skin following 
an internal standard procedure [32]. The SC and viable 
epidermis (VE) were obtained by incubating HE in a 
Petri dish with 10  mL of 0.005% trypsin in pH 7.4 PBS 
at 37 ±  1  °C for 18 h. The integrity of HE was checked 
before the permeation studies by measuring the electrical 
resistance of HE or SC [33].
The membrane was placed on the Franz diffusion cell 
whose receptor compartment was filled with degassed 
0.9% w/v NaCl solution containing 0.01% w/v NaN3 as 
preservative. The donor compartment was filled with 
0.5  mL of aqueous suspension or formulations loaded 
with 3  mg/mL PMA-IONs. The system was kept at 
32 ± 1 °C throughout all the experiment. At experiment 
end, the receptor phase was withdrawn and analyzed by 
ICP-OES for determining the iron amount permeated 
through the membrane after 24 h (Q24).
Afterwards, the membrane was gently cleaned to 
eliminate the unabsorbed PMA-IONs. Subsequently, 
the sample was dried, weighted and analyzed by ICP-
OES to quantify the iron amount retained into the 
membrane (Qret). The results were expressed as the 
average of parallel experiments, performed in triplicate. 
As discussed by Musazzi et al. [33], the Qret/Q24,HE ratio 
was calculated as parameter to estimate the affinity of 
PMA-IONs to be retained or to permeate through HE. 
The higher the Qret/Q24,HE, the higher the retention 
affinity of nanoparticles.
Nanoparticles quantification by ICP analysis
For the ICP-OES analysis of the samples collected from 
the Franz diffusion cell receptor chambers, 3 mL of aqua 
regia were added to the samples and, after 72 h, the sam-
ples were diluted with 7 mL of distilled water. All samples 
were measured in triplicate with Optima 7000 DV ICP-
OES (Perkin Elmer, Waltham, USA).
Epidermis fixation protocol and transmission electron 
microscopy (TEM) analysis
For the ultrastructural analysis a fragment of each skin 
specimen was fixed in 2.5% buffered glutaraldehyde, 
washed with buffer and post-fixed in 1.5% buffered 
OsO4 at 4  °C for 2  h. The specimens were dehydrated 
in a graded series of alcohol solution and embedded in 
Epon. The sections were then stained with uranyl acetate 
and lead citrate and examined in a FEI Tecnai G2 Spirit 
microscope equipped with a digital camera (Oregon, 
USA). The obtained sections were deposited on Formvar/
carbon-coated copper grid.
EDX analysis
The STEM image and energy dispersive X-ray analy-
sis (EDX) were performed using a ZEISS LIBRA200FE 
TEM equipped with an HAADF-STEM (high angular 
annular dark field scanning electron microscopy) and 
EDS—Oxford INCA Energy TEM 200. The EDX analy-
sis was performed on the epithelial tissue exposed to the 
IONs for 24 h and prepared as described in the previous 
paragraph.
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